世界の加齢性黄斑変性症市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Age-related Macular Degeneration Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z00455 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、加齢性黄斑変性症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。加齢性黄斑変性症の種類別市場規模（湿性AMD、乾性AMD）、用途別市場規模（ドラッグストア、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・加齢性黄斑変性症の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：湿性AMD、乾性AMD ・用途別分析2016年-2026年：ドラッグストア、病院、その他 ・加齢性黄斑変性症の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・加齢性黄斑変性症のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・加齢性黄斑変性症のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・加齢性黄斑変性症の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・加齢性黄斑変性症の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Age-related Macular Degeneration market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Age-related Macular Degeneration size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Age-related Macular Degeneration market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Age-related Macular Degeneration market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Wet AMD
Dry AMD

Market segment by Application, can be divided into
Drugstore
Hospital
Others

Market segment by players, this report covers
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Age-related Macular Degeneration
1.2 Classification of Age-related Macular Degeneration by Type
1.2.1 Overview: Global Age-related Macular Degeneration Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Age-related Macular Degeneration Revenue Market Share by Type in 2020
1.2.3 Wet AMD
1.2.4 Dry AMD
1.3 Global Age-related Macular Degeneration Market by Application
1.3.1 Overview: Global Age-related Macular Degeneration Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Age-related Macular Degeneration Market Size & Forecast
1.5 Global Age-related Macular Degeneration Market Size and Forecast by Region
1.5.1 Global Age-related Macular Degeneration Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Age-related Macular Degeneration Market Size by Region, (2016-2021)
1.5.3 North America Age-related Macular Degeneration Market Size and Prospect (2016-2026)
1.5.4 Europe Age-related Macular Degeneration Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Age-related Macular Degeneration Market Size and Prospect (2016-2026)
1.5.6 South America Age-related Macular Degeneration Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Age-related Macular Degeneration Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Age-related Macular Degeneration Market Drivers
1.6.2 Age-related Macular Degeneration Market Restraints
1.6.3 Age-related Macular Degeneration Trends Analysis
2 Company Profiles
2.1 Bayer HealthCare
2.1.1 Bayer HealthCare Details
2.1.2 Bayer HealthCare Major Business
2.1.3 Bayer HealthCare Age-related Macular Degeneration Product and Solutions
2.1.4 Bayer HealthCare Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bayer HealthCare Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Product and Solutions
2.2.4 F. Hoffmann-La Roche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Age-related Macular Degeneration Product and Solutions
2.3.4 Novartis Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Regeneron Pharmaceuticals
2.4.1 Regeneron Pharmaceuticals Details
2.4.2 Regeneron Pharmaceuticals Major Business
2.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Product and Solutions
2.4.4 Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.5 Alcon
2.5.1 Alcon Details
2.5.2 Alcon Major Business
2.5.3 Alcon Age-related Macular Degeneration Product and Solutions
2.5.4 Alcon Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Alcon Recent Developments and Future Plans
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Age-related Macular Degeneration Product and Solutions
2.6.4 Allergan Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Allergan Recent Developments and Future Plans
2.7 Avalanche
2.7.1 Avalanche Details
2.7.2 Avalanche Major Business
2.7.3 Avalanche Age-related Macular Degeneration Product and Solutions
2.7.4 Avalanche Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Avalanche Recent Developments and Future Plans
2.8 Bausch+Lomb
2.8.1 Bausch+Lomb Details
2.8.2 Bausch+Lomb Major Business
2.8.3 Bausch+Lomb Age-related Macular Degeneration Product and Solutions
2.8.4 Bausch+Lomb Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bausch+Lomb Recent Developments and Future Plans
2.9 Gilead Sciences
2.9.1 Gilead Sciences Details
2.9.2 Gilead Sciences Major Business
2.9.3 Gilead Sciences Age-related Macular Degeneration Product and Solutions
2.9.4 Gilead Sciences Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Gilead Sciences Recent Developments and Future Plans
2.10 Iconic Therapeutics
2.10.1 Iconic Therapeutics Details
2.10.2 Iconic Therapeutics Major Business
2.10.3 Iconic Therapeutics Age-related Macular Degeneration Product and Solutions
2.10.4 Iconic Therapeutics Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Iconic Therapeutics Recent Developments and Future Plans
2.11 Neurotech Pharmaceuticals
2.11.1 Neurotech Pharmaceuticals Details
2.11.2 Neurotech Pharmaceuticals Major Business
2.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Product and Solutions
2.11.4 Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Neurotech Pharmaceuticals Recent Developments and Future Plans
2.12 Ohr Pharmaceutical
2.12.1 Ohr Pharmaceutical Details
2.12.2 Ohr Pharmaceutical Major Business
2.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Product and Solutions
2.12.4 Ohr Pharmaceutical Age-related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Ohr Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Age-related Macular Degeneration Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Age-related Macular Degeneration Players Market Share
3.2.2 Top 10 Age-related Macular Degeneration Players Market Share
3.2.3 Market Competition Trend
3.3 Age-related Macular Degeneration Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Age-related Macular Degeneration Revenue and Market Share by Type (2016-2021)
4.2 Global Age-related Macular Degeneration Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Age-related Macular Degeneration Revenue Market Share by Application (2016-2021)
5.2 Age-related Macular Degeneration Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Age-related Macular Degeneration Revenue by Type (2016-2026)
6.2 North America Age-related Macular Degeneration Revenue by Application (2016-2026)
6.3 North America Age-related Macular Degeneration Market Size by Country
6.3.1 North America Age-related Macular Degeneration Revenue by Country (2016-2026)
6.3.2 United States Age-related Macular Degeneration Market Size and Forecast (2016-2026)
6.3.3 Canada Age-related Macular Degeneration Market Size and Forecast (2016-2026)
6.3.4 Mexico Age-related Macular Degeneration Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Age-related Macular Degeneration Revenue by Type (2016-2026)
7.2 Europe Age-related Macular Degeneration Revenue by Application (2016-2026)
7.3 Europe Age-related Macular Degeneration Market Size by Country
7.3.1 Europe Age-related Macular Degeneration Revenue by Country (2016-2026)
7.3.2 Germany Age-related Macular Degeneration Market Size and Forecast (2016-2026)
7.3.3 France Age-related Macular Degeneration Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Age-related Macular Degeneration Market Size and Forecast (2016-2026)
7.3.5 Russia Age-related Macular Degeneration Market Size and Forecast (2016-2026)
7.3.6 Italy Age-related Macular Degeneration Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Age-related Macular Degeneration Revenue by Type (2016-2026)
8.2 Asia-Pacific Age-related Macular Degeneration Revenue by Application (2016-2026)
8.3 Asia-Pacific Age-related Macular Degeneration Market Size by Region
8.3.1 Asia-Pacific Age-related Macular Degeneration Revenue by Region (2016-2026)
8.3.2 China Age-related Macular Degeneration Market Size and Forecast (2016-2026)
8.3.3 Japan Age-related Macular Degeneration Market Size and Forecast (2016-2026)
8.3.4 South Korea Age-related Macular Degeneration Market Size and Forecast (2016-2026)
8.3.5 India Age-related Macular Degeneration Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Age-related Macular Degeneration Market Size and Forecast (2016-2026)
8.3.7 Australia Age-related Macular Degeneration Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Age-related Macular Degeneration Revenue by Type (2016-2026)
9.2 South America Age-related Macular Degeneration Revenue by Application (2016-2026)
9.3 South America Age-related Macular Degeneration Market Size by Country
9.3.1 South America Age-related Macular Degeneration Revenue by Country (2016-2026)
9.3.2 Brazil Age-related Macular Degeneration Market Size and Forecast (2016-2026)
9.3.3 Argentina Age-related Macular Degeneration Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Age-related Macular Degeneration Revenue by Type (2016-2026)
10.2 Middle East & Africa Age-related Macular Degeneration Revenue by Application (2016-2026)
10.3 Middle East & Africa Age-related Macular Degeneration Market Size by Country
10.3.1 Middle East & Africa Age-related Macular Degeneration Revenue by Country (2016-2026)
10.3.2 Turkey Age-related Macular Degeneration Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Age-related Macular Degeneration Market Size and Forecast (2016-2026)
10.3.4 UAE Age-related Macular Degeneration Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Age-related Macular Degeneration Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Age-related Macular Degeneration Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Age-related Macular Degeneration Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Age-related Macular Degeneration Revenue (USD Million) by Region (2016-2021)
Table 5. Global Age-related Macular Degeneration Revenue Market Share by Region (2021-2026)
Table 6. Bayer HealthCare Corporate Information, Head Office, and Major Competitors
Table 7. Bayer HealthCare Major Business
Table 8. Bayer HealthCare Age-related Macular Degeneration Product and Solutions
Table 9. Bayer HealthCare Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Major Business
Table 12. F. Hoffmann-La Roche Age-related Macular Degeneration Product and Solutions
Table 13. F. Hoffmann-La Roche Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Age-related Macular Degeneration Product and Solutions
Table 17. Novartis Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Regeneron Pharmaceuticals Major Business
Table 20. Regeneron Pharmaceuticals Age-related Macular Degeneration Product and Solutions
Table 21. Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Alcon Corporate Information, Head Office, and Major Competitors
Table 23. Alcon Major Business
Table 24. Alcon Age-related Macular Degeneration Product and Solutions
Table 25. Alcon Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Allergan Corporate Information, Head Office, and Major Competitors
Table 27. Allergan Major Business
Table 28. Allergan Age-related Macular Degeneration Product and Solutions
Table 29. Allergan Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Avalanche Corporate Information, Head Office, and Major Competitors
Table 31. Avalanche Major Business
Table 32. Avalanche Age-related Macular Degeneration Product and Solutions
Table 33. Avalanche Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bausch+Lomb Corporate Information, Head Office, and Major Competitors
Table 35. Bausch+Lomb Major Business
Table 36. Bausch+Lomb Age-related Macular Degeneration Product and Solutions
Table 37. Bausch+Lomb Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 39. Gilead Sciences Major Business
Table 40. Gilead Sciences Age-related Macular Degeneration Product and Solutions
Table 41. Gilead Sciences Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Iconic Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Iconic Therapeutics Major Business
Table 44. Iconic Therapeutics Age-related Macular Degeneration Product and Solutions
Table 45. Iconic Therapeutics Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Neurotech Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Neurotech Pharmaceuticals Major Business
Table 48. Neurotech Pharmaceuticals Age-related Macular Degeneration Product and Solutions
Table 49. Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Ohr Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 51. Ohr Pharmaceutical Major Business
Table 52. Ohr Pharmaceutical Age-related Macular Degeneration Product and Solutions
Table 53. Ohr Pharmaceutical Age-related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Age-related Macular Degeneration Revenue (USD Million) by Players (2019-2021)
Table 55. Global Age-related Macular Degeneration Revenue Share by Players (2019-2021)
Table 56. Breakdown of Age-related Macular Degeneration by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Age-related Macular Degeneration Players Head Office, Products and Services Provided
Table 58. Age-related Macular Degeneration Mergers & Acquisitions in the Past Five Years
Table 59. Age-related Macular Degeneration New Entrants and Expansion Plans
Table 60. Global Age-related Macular Degeneration Revenue (USD Million) by Type (2016-2021)
Table 61. Global Age-related Macular Degeneration Revenue Share by Type (2016-2021)
Table 62. Global Age-related Macular Degeneration Revenue Forecast by Type (2021-2026)
Table 63. Global Age-related Macular Degeneration Revenue by Application (2016-2021)
Table 64. Global Age-related Macular Degeneration Revenue Forecast by Application (2021-2026)
Table 65. North America Age-related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Age-related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Age-related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Age-related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Age-related Macular Degeneration Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Age-related Macular Degeneration Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Age-related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Age-related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Age-related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Age-related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Age-related Macular Degeneration Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Age-related Macular Degeneration Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Age-related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Age-related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Age-related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Age-related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Age-related Macular Degeneration Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Age-related Macular Degeneration Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Age-related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Age-related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Age-related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Age-related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Age-related Macular Degeneration Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Age-related Macular Degeneration Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Age-related Macular Degeneration Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Age-related Macular Degeneration Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Age-related Macular Degeneration Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Age-related Macular Degeneration Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Age-related Macular Degeneration Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Age-related Macular Degeneration Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Age-related Macular Degeneration Picture
Figure 2. Global Age-related Macular Degeneration Revenue Market Share by Type in 2020
Figure 3. Wet AMD
Figure 4. Dry AMD
Figure 5. Age-related Macular Degeneration Revenue Market Share by Application in 2020
Figure 6. Drugstore Picture
Figure 7. Hospital Picture
Figure 8. Others Picture
Figure 9. Global Age-related Macular Degeneration Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Age-related Macular Degeneration Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Age-related Macular Degeneration Revenue Market Share by Region (2016-2026)
Figure 12. Global Age-related Macular Degeneration Revenue Market Share by Region in 2020
Figure 13. North America Age-related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Age-related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Age-related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Age-related Macular Degeneration Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Age-related Macular Degeneration Market Drivers
Figure 18. Age-related Macular Degeneration Market Restraints
Figure 19. Age-related Macular Degeneration Market Trends
Figure 20. Bayer HealthCare Recent Developments and Future Plans
Figure 21. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Regeneron Pharmaceuticals Recent Developments and Future Plans
Figure 24. Alcon Recent Developments and Future Plans
Figure 25. Allergan Recent Developments and Future Plans
Figure 26. Avalanche Recent Developments and Future Plans
Figure 27. Bausch+Lomb Recent Developments and Future Plans
Figure 28. Gilead Sciences Recent Developments and Future Plans
Figure 29. Iconic Therapeutics Recent Developments and Future Plans
Figure 30. Neurotech Pharmaceuticals Recent Developments and Future Plans
Figure 31. Ohr Pharmaceutical Recent Developments and Future Plans
Figure 33. Global Age-related Macular Degeneration Revenue Share by Players in 2020
Figure 34. Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Age-related Macular Degeneration Revenue Market Share in 2020
Figure 36. Global Top 10 Players Age-related Macular Degeneration Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Age-related Macular Degeneration Revenue Share by Type in 2020
Figure 39. Global Age-related Macular Degeneration Market Share Forecast by Type (2021-2026)
Figure 40. Global Age-related Macular Degeneration Revenue Share by Application in 2020
Figure 41. Global Age-related Macular Degeneration Market Share Forecast by Application (2021-2026)
Figure 42. North America Age-related Macular Degeneration Sales Market Share by Type (2016-2026)
Figure 43. North America Age-related Macular Degeneration Sales Market Share by Application (2016-2026)
Figure 44. North America Age-related Macular Degeneration Revenue Market Share by Country (2016-2026)
Figure 45. United States Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Age-related Macular Degeneration Sales Market Share by Type (2016-2026)
Figure 49. Europe Age-related Macular Degeneration Sales Market Share by Application (2016-2026)
Figure 50. Europe Age-related Macular Degeneration Revenue Market Share by Country (2016-2026)
Figure 51. Germany Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Age-related Macular Degeneration Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Age-related Macular Degeneration Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Age-related Macular Degeneration Revenue Market Share by Region (2016-2026)
Figure 59. China Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Age-related Macular Degeneration Sales Market Share by Type (2016-2026)
Figure 66. South America Age-related Macular Degeneration Sales Market Share by Application (2016-2026)
Figure 67. South America Age-related Macular Degeneration Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Age-related Macular Degeneration Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Age-related Macular Degeneration Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Age-related Macular Degeneration Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Age-related Macular Degeneration Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

---